Akeso secures China NMPA authorisation for ivonescimab combo
The authorisation is based on data from the HARMONi-6 multi-centre Phase III study that was conducted in China.
Drug Development
Remepy secures $36m funding for hybrid drug pipeline expansion
Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat
Alfasigma signs agreement to acquire Nordic Group
BeOne and Revolution Medicines partner for oncology therapies
Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront
Innovent and Daiichi Sankyo sign deal for Vanflyta in China
Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs
